<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
EWTX
Edgewise Therapeutics
$
()


  • EMA grants Orphan Drug Designations for Edgewise's sevasemten to treat Becker

    4/23/2024 - 08:10am
  • Edgewise Therapeutics price target raised by $4 at RBC Capital, here's why

    4/22/2024 - 08:12am
  • Edgewise reports 'positive' two-year topline results from ARCH trial

    4/15/2024 - 16:12pm
  • Micron upgraded, Foot Locker downgraded: Wall Street's top analyst calls

    3/7/2024 - 09:53am
  • Edgewise Therapeutics initiated with bullish view at Piper Sandler, here's why

    3/7/2024 - 07:24am
  • Edgewise Therapeutics reports Q4 EPS (47c), consensus (43c)

    2/22/2024 - 08:05am
  • FDA grants Edgewise fast track designation for EDG-5506 to treat Duchenne

    2/13/2024 - 08:10am
  • Edgewise Therapeutics management to meet with Piper Sandler

    2/7/2024 - 04:55am
  • Edgewise Therapeutics management to meet with Piper Sandler

    2/6/2024 - 05:55am
  • Edgewise Therapeutics management to meet with Piper Sandler

    2/5/2024 - 04:55am
  • Edgewise Therapeutics management to meet with Piper Sandler

    1/31/2024 - 07:50am
  • Fly Insider: Edgewise, Arch Resources among week's notable insider trades

    1/29/2024 - 15:48pm
  • Edgewise Therapeutics 21.8M share Secondary priced at $11.00

    1/19/2024 - 10:11am
  • Edgewise, Caribou higher after WSJ report of Cytokinetics buyout

    1/8/2024 - 13:02pm
  • Edgewise shares still reflect limited credit for EDG-7500, says Wedbush

    12/28/2023 - 07:41am
dynamic_feed Breaking News